Table 3:

Postoperative data

Group A (N = 18)Group B (N = 19)P-value
VAC therapy015 (79%)
Mean VAC therapy (days)10 (±7)
Wound closure post-SCF10 (±5)15 (±7)0.012
LOS in the hospital (days)22 (±12)26 (±14)0.34
Total antimicrobial therapy16 (±9)22 (±11)0.078
Recurrent SCF1 (6%)4 (21%)0.46
Follow-up (months)8 (±3)10 (±6)
Overall mortality01 (5%)1.00
Group A (N = 18)Group B (N = 19)P-value
VAC therapy015 (79%)
Mean VAC therapy (days)10 (±7)
Wound closure post-SCF10 (±5)15 (±7)0.012
LOS in the hospital (days)22 (±12)26 (±14)0.34
Total antimicrobial therapy16 (±9)22 (±11)0.078
Recurrent SCF1 (6%)4 (21%)0.46
Follow-up (months)8 (±3)10 (±6)
Overall mortality01 (5%)1.00

Bold values indicates statistically significant.

VAC: vacuum assisted closure therapy; LOS: length of stay in hospital.

Table 3:

Postoperative data

Group A (N = 18)Group B (N = 19)P-value
VAC therapy015 (79%)
Mean VAC therapy (days)10 (±7)
Wound closure post-SCF10 (±5)15 (±7)0.012
LOS in the hospital (days)22 (±12)26 (±14)0.34
Total antimicrobial therapy16 (±9)22 (±11)0.078
Recurrent SCF1 (6%)4 (21%)0.46
Follow-up (months)8 (±3)10 (±6)
Overall mortality01 (5%)1.00
Group A (N = 18)Group B (N = 19)P-value
VAC therapy015 (79%)
Mean VAC therapy (days)10 (±7)
Wound closure post-SCF10 (±5)15 (±7)0.012
LOS in the hospital (days)22 (±12)26 (±14)0.34
Total antimicrobial therapy16 (±9)22 (±11)0.078
Recurrent SCF1 (6%)4 (21%)0.46
Follow-up (months)8 (±3)10 (±6)
Overall mortality01 (5%)1.00

Bold values indicates statistically significant.

VAC: vacuum assisted closure therapy; LOS: length of stay in hospital.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close